Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-08-08

FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Slate Run Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved Slate Run Pharmaceuticals' generic diltiazem hydrochloride under an original ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diltiazem hydrochloride (Diltiazem hydrochloride)

Snippet

ORIG AP for DILTIAZEM HYDROCHLORIDE (DILTIAZEM HYDROCHLORIDE)